Need To Know: Analysts Are Much More Bullish On Liquidia Corporation (NASDAQ:LQDA)
Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year
A Look At Liquidia (LQDA) Valuation After YUTREPIA Fueled Profitability And Strong First Quarter Results
Earnings Estimates Moving Higher for Liquidia Corporation (LQDA): Time to Buy?
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
Results: Liquidia Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease
Liquidia Corporation (LQDA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
These Analysts Boost Their Forecasts On Liquidia After Upbeat Q1 Results
HC Wainwright & Co. Maintains Buy on Liquidia, Raises Price Target to $67
Wells Fargo Maintains Overweight on Liquidia, Raises Price Target to $62
Liquidia Corp (LQDA) Q1 2026 Earnings Call Highlights: Record Growth and Strategic Expansion
Liquidia: Yutrepia's Launch Momentum Is Approaching A Ceiling (Rating Downgrade)
Liquidia (LQDA) Hits All-Time High as Yutrepia Drives Swing to Profits
Liquidia (LQDA) Q1 2026 Earnings Transcript
BDTX Shares Gain 11% in a Week: Here's What You Should Know
Needham Maintains Buy on Liquidia, Raises Price Target to $70
Liquidia Q1 Earnings Call Highlights
Liquidia (LQDA) Shares Rise After Strong Q1 Earnings and Revenue Beat
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.